InvestorsHub Logo
Followers 0
Posts 457
Boards Moderated 0
Alias Born 10/07/2012

Re: dawginlife post# 111083

Sunday, 02/10/2013 2:45:25 PM

Sunday, February 10, 2013 2:45:25 PM

Post# of 345856
<< ...company has chosen a high enough death count that they will be certain the MOS for both arms have been reached ...>>

Pancreatic and first line NSCLC are not blinded trials, company should know within days when MOS for either arm has been reached and could use MOS in Bavi arm for the trigger point.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News